Skip to main content
. 2022 Mar 24;12:5132. doi: 10.1038/s41598-022-09241-6

Figure 4.

Figure 4

LAS194046 and fluticasone propionate combination shows additive/synergic effects on human neutrophil inflammation. Neutrophils from healthy subjects, severe asthma and COPD patients were pre-incubated with sub-effective concentrations of LAS194046, fluticasone propionate or its combination during 1 h followed by cell stimulation with (A) LPS (1 µg/ml) or (B) cigarette smoke extract (CSE 5%) for 6 h to measure IL-8 and MMP-9 release. The results are expressed as the mean ± SD (n = 3 each for cells from healthy controls, severe asthma and COPD patients in independent experiments with triplicate samples). A two-way ANOVA was followed by a post hoc Bonferroni test. *p < 0.05 vs. cells from healthy patients.